title: Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2(V617F) mutational status.
authors.forename: K
authors.initials: K
authors.lastname: Ohyashiki
authors.forename: D
authors.initials: D
authors.lastname: Akahane
authors.forename: A
authors.initials: A
authors.lastname: Gotoh
authors.forename: Y
authors.initials: Y
authors.lastname: Ito
authors.forename: T
authors.initials: T
authors.lastname: Tauchi
authors.forename: K
authors.initials: K
authors.lastname: Miyazawa
authors.forename: Y
authors.initials: Y
authors.lastname: Kimura
authors.forename: J H
authors.initials: JH
authors.lastname: Ohyashiki
mesh_terms: D000328:Adult; D000368:Aged; D004252:DNA Mutational Analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D053614:Janus Kinase 2 / Q000235:genetics* / Q000502:physiology; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D010976:Platelet Count; D011087:Polycythemia Vera / Q000097:blood / Q000150:complications* / Q000235:genetics; D012306:Risk; D013920:Thrombocythemia, Essential / Q000097:blood / Q000150:complications / Q000235:genetics; D019851:Thrombophilia / Q000097:blood / Q000209:etiology / Q000235:genetics*; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology*
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2